Jan 14, 2022

Featuring perspectives from Drs. Carey Anders, Virginia Borges, Sara Hurvitz and Ian Krop, moderated by Dr. Lisa Carey, including the following topics:

• Considerations in the care of patients with HER2-positive localized breast cancer (BC) (0:00)
• Optimizing the management of HER2-positive metastatic BC (23:19)
• Treatment...

Jan 14, 2022

Featuring perspectives from Drs. Aditya Bardia, Kevin Kalinsky and Joyce O’Shaughnessy, moderated by Dr. Erika Hamilton, including the following topics:

• Current Role of Genomic Classifiers to Inform Decision-Making for Patients with ER-Positive Localized Breast Cancer (0:00)
• Emerging Treatment Strategies for Patients...

Jan 11, 2022

Featuring perspectives from Dr Hope Rugo, including the following topics:

• Introduction: DESTINY-Breast03 Trial (0:00)
• Case: A woman in her mid-60s with ER/PR-negative, HER2-positive metastatic breast cancer (mBC) — Raman Sood, MD (11:57)
• Case: A woman in her late 60s with ER/PR-negative, HER2-positive mBC — Rohit...

Jan 8, 2022

Featuring perspectives from Drs Sara Hurvitz, Rita Nanda and Melinda Telli, moderated by Dr Hope Rugo, including the following topics:

• Therapeutic strategies for patients with localized triple-negative breast cancer (TNBC) (0:00)
• Current and future role of PARP inhibitors in metastatic TNBC (28:28)
• Optimal integration...

Jan 4, 2022

Featuring perspectives from Dr Kevin Kalinsky, including the following topics:

• Introduction (0:00)
• Journal Club with Dr Kalinsky (1:08)
• Case: A woman in her mid-60s with ER-positive, PR-negative, HER2-negative metastatic breast cancer (mBC) — Ann Partridge, MD, MPH (17:55)
• Case: A woman in her early 30s with...